Fulgent Genetics, Inc. Common Stock (NASDAQ: FLGT) last traded at $19.90, down 0.10% on the session. The quote above updates while this page is open; the figures below are drawn from Fulgent Genetics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Fulgent Genetics, Inc. Common Stock trades on NASDAQ under the ticker FLGT. Its market capitalisation is $547.55 million.
Valuation measures for Fulgent Genetics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $547.55M |
|---|---|
| Enterprise value | $614.49M |
| Price / sales | 1.69 |
| Price / book | 0.55 |
| Beta | 0.83 |
Trailing-twelve-month figures tagged in Fulgent Genetics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $323.93M |
|---|---|
| Net income (TTM) | -$84.46M |
| Gross margin | 35.58% |
| Operating margin | -37.75% |
| Return on equity | -8.43% |
| Cash | $26.30M |
Range and volume for FLGT over the past 52 weeks.
| 52-week high | $31.04 |
|---|---|
| 52-week low | $13.46 |
| Volume | 309.4K |
| Average volume | 338.7K |
| Previous close | $19.92 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.